Comparison · NCT05225298-7f8b57cf
Static Frequency vs Dynamic Frequency: Hospitalizations
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Static Frequency vs Dynamic Frequency: Hospitalizations. Trial comparisons, record NCT05225298-7f8b57cf. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05225298-7f8b57cf
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.29 | 0.264 | 0.318 | wilson | |
| Risk in group 2 | 0.336 | 0.311 | 0.362 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0464 | -0.0834 | -0.00891 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.862 | 0.764 | 0.973 | log | |
| Odds ratio, group 1 over group 2 | 0.806 | 0.677 | 0.96 | log | |
| Number needed to treat, for one fewer participant with the outcome on Static Frequency than on Dynamic Frequency | 21.6 | 12 | 112 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Static Frequency | Test based screening for SARS-CoV-2 every two weeks | 310 | 1,069 | OG000 |
| Group 2 | Dynamic Frequency | Test based screening for SARS-CoV-2 ranging from once a week to once every four weeks anchored to county COVID-19 case rates | 444 | 1,320 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Hospitalizations
- Description
- Time frame
- 4 months
- Population
Source ClinicalTrials.gov
Trial
- Title
- SARS-COV-2 Screening in Dialysis Facilities
- NCT number
- NCT05225298
- Phases
- NA
- Conditions
- End-stage Renal Disease, SARS-CoV-2 Acute Respiratory Disease, Dialysis; Complications
- Interventions
- Offering SARS-CoV-2 test
- Lead sponsor
- Stanford University
- Results first posted
- 2024-10-30
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT05225298?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT05225298-7f8b57cf